142 related articles for article (PubMed ID: 26828850)
1. Planning Treatment and Assessing Recovery in Participants With Dual Diagnosis: Preliminary Evaluation of a New Clinical Tool.
Noel V; Woods M; Routhier J; Drake R
J Dual Diagn; 2016; 12(1):55-62. PubMed ID: 26828850
[TBL] [Abstract][Full Text] [Related]
2. The Dual Diagnosis Capability of Residential Addiction Treatment centres: priorities and confidence to improve capability following a review process.
Matthews H; Kelly PJ; Deane FP
Drug Alcohol Rev; 2011 Mar; 30(2):195-9. PubMed ID: 21355921
[TBL] [Abstract][Full Text] [Related]
3. A dual diagnosis typology to improve diagnosis and treatment of dual disorder patients.
Zimberg S
J Psychoactive Drugs; 1999; 31(1):47-51. PubMed ID: 10332638
[TBL] [Abstract][Full Text] [Related]
4. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
[TBL] [Abstract][Full Text] [Related]
5. Innovations in integrated dual diagnosis treatment in public managed care: the Choate dual diagnosis case rate program.
Minkoff K; Regner J
J Psychoactive Drugs; 1999; 31(1):3-12. PubMed ID: 10332633
[TBL] [Abstract][Full Text] [Related]
6. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
[TBL] [Abstract][Full Text] [Related]
7. Organizational capacity to address co-occurring substance use and psychiatric disorders: assessing variation by level of care.
Lambert-Harris C; Saunders EC; McGovern MP; Xie H
J Addict Med; 2013; 7(1):25-32. PubMed ID: 23188042
[TBL] [Abstract][Full Text] [Related]
8. A family intervention program for dual disorders.
Mueser KT; Fox L
Community Ment Health J; 2002 Jun; 38(3):253-70. PubMed ID: 12046678
[TBL] [Abstract][Full Text] [Related]
9. Behavioral interventions for dual-diagnosis patients.
Goldsmith RJ; Garlapati V
Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
[TBL] [Abstract][Full Text] [Related]
10. Development of a comprehensive measure to assess clinical issues in dual diagnosis patients: The Substance Use Event Survey for Severe Mental Illness.
Bennett ME; Bellack AS; Gearon JS
Addict Behav; 2006 Dec; 31(12):2249-67. PubMed ID: 16678352
[TBL] [Abstract][Full Text] [Related]
11. The European Adolescent Assessment Dialogue (EuroADAD): a psychometric evaluation.
Czobor P; Bácskai E; Oberg D; Haack MJ; Gerevich J
Eur Addict Res; 2011; 17(6):302-15. PubMed ID: 21934309
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness.
Buckley PF
J Clin Psychiatry; 2006; 67 Suppl 7():5-9. PubMed ID: 16961418
[TBL] [Abstract][Full Text] [Related]
13. Convergent validity of the ASAM criteria in co-occurring disorders.
Stallvik M; Nordahl HM
J Dual Diagn; 2014; 10(2):68-78. PubMed ID: 25392248
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Integrated Dual Diagnosis Treatment (IDDT) in severe mental illness outpatients with a co-occurring substance use disorder.
Kikkert M; Goudriaan A; de Waal M; Peen J; Dekker J
J Subst Abuse Treat; 2018 Dec; 95():35-42. PubMed ID: 30352668
[TBL] [Abstract][Full Text] [Related]
15. Real-world evaluation of the Resident Assessment Instrument-Mental Health assessment system.
Urbanoski KA; Mulsant BH; Willett P; Ehtesham S; Rush B
Can J Psychiatry; 2012 Nov; 57(11):687-95. PubMed ID: 23149284
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders.
Choi S; Adams SM; Morse SA; MacMaster S
Subst Use Misuse; 2015 Apr; 50(5):653-63. PubMed ID: 25587672
[TBL] [Abstract][Full Text] [Related]
17. A scale for assessing the stage of substance abuse treatment in persons with severe mental illness.
McHugo GJ; Drake RE; Burton HL; Ackerson TH
J Nerv Ment Dis; 1995 Dec; 183(12):762-7. PubMed ID: 8522938
[TBL] [Abstract][Full Text] [Related]
18. Approach to treatment of mental illness and substance dependence in remote Indigenous communities: results of a mixed methods study.
Nagel T; Robinson G; Condon J; Trauer T
Aust J Rural Health; 2009 Aug; 17(4):174-82. PubMed ID: 19664081
[TBL] [Abstract][Full Text] [Related]
19. Severe mental illness and addictions: assessment considerations.
Carey KB; Correia CJ
Addict Behav; 1998; 23(6):735-48. PubMed ID: 9801713
[TBL] [Abstract][Full Text] [Related]
20. Towards quality indicators for assertive outreach programmes for severely impaired substance abusers: concept mapping with Dutch experts.
Roeg D; van de Goor I; Garretsen H
Int J Qual Health Care; 2005 Jun; 17(3):203-8. PubMed ID: 15788464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
